Cyvex, Solanic Partner for SolaThin Distribution

IRVINE, Calif., and VEENDAM, The NetherlandsCyvex Nutrition will assume all duties relating to SolaThins sales, promotion, support and further development, according to a distribution alliance it made with Solanic. SolaThin is a weight-management ingredient available for the food, beverage and dietary supplement industries.

 Under this new alliance, SolaThin will also be further studied in a human clinical trial involving 60 adult subjects, with three treatment arms expected to be completed by fourth quarter of 2011.

SolaThin, introduced to the U.S. market in March 2011 by Cyvex Nutrition, is a pure potato protein extract consisting of several low-molecular weight proteins, including protease inhibitor PI-2. PI-2 enables the release of cholecystokinin (CKK), a naturally occurring peptide clinically shown to produce a feeling of gastric fullness, and thereby helping reduce food consumption. Additionally, SolaThin contains no added compounds and features more than 90-percent protein, PI-2 included, to promote satiety and healthful, effective weight control.

Cyvex Nutrition provides proprietary, condition-specific ingredients to the nutraceutical. In late 2010, Cyvex Nutrition was acquired by Omega Protein Corp., a producer of omega-3 fish oil and specialty ingredients for use in functional foods and nutritional supplements. Every Cyvex Nutrition ingredient is guaranteed by the company's NutriPrint® quality assurance system, which includes identity testing of incoming raw materials through FT-NIR, third-party certification by independent laboratories for active ingredients, microbiology, heavy metals and pesticide and solvent residue when applicable.

Solanic is an AVEBE Group company and produces non-GMO natural vegetable proteins. The Solanic organization is fully integrated in the regular AVEBE quality, safety and sustainability systems and procedures.